3Korppi M,Heiskanen-Kosma T,Kleemola M.Incidence of community-acquired pneumonia in children caused by Mycoplasna pneumoniae:serological results of a prospective,population-based study in primary health care.Respirology,2004,9:109-114.
4Principi N,Esposito S.Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients.Curr Opin Infect Dis,2002,15:295-300.
6Bebear CM,Pereyre S.Mechanisms of drug resistance in Mycoplasma pneumoniae Curr Drug Targets Infect Disord,2005,5:263-271.
7Matsuoka M,Narita M,Olazaki N,et al.Charscterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.Antimicrob Agents Chemother,2004,48:4624-4630.
8Lee KY,lee HS,Hong JH,et al.Role of prednisone treatment in severe Mycoplasma pneumoniae in children.Pediatr Pulmonol,2006,41:263-268.
9Okazaki N,Narita M,Yamada S,et al.Characteristics of macrolide-resistant Mycoplasma pneumoniae strnins isolated from patients and induced with erythhromycin in vitro.Microbiol Immunol,2001,45:617-620.
10Lind K,Bentzon MW.Ten and a half years seroepidemiology of mycoplasma pneumoniae infection in Denmark.Epidemiol Infect,1991,107:189-199.
